These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10595504)

  • 21. Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis.
    Pelisch N; Dan T; Ichimura A; Sekiguchi H; Vaughan DE; van Ypersele de Strihou C; Miyata T
    PLoS One; 2015; 10(4):e0124510. PubMed ID: 25915660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.
    Hafler DA
    J Clin Invest; 1999 Sep; 104(5):527-9. PubMed ID: 10487765
    [No Abstract]   [Full Text] [Related]  

  • 24. Demyelinating disease: evolution of a paradigm.
    Waksman BH
    Neurochem Res; 1999 Apr; 24(4):491-5. PubMed ID: 10227681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental autoimmune encephalomyelitis].
    Cornet A; Vizler C; Liblau R
    Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.
    Aharoni R
    Expert Rev Clin Immunol; 2013 May; 9(5):423-40. PubMed ID: 23634737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Natalizumab: an antibody targeting α4-integrin].
    Nakahara J
    Brain Nerve; 2014 Oct; 66(10):1149-58. PubMed ID: 25296869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
    Binyamin O; Larush L; Frid K; Keller G; Friedman-Levi Y; Ovadia H; Abramsky O; Magdassi S; Gabizon R
    Int J Nanomedicine; 2015; 10():7165-74. PubMed ID: 26648720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antilymphocytic globulin and its immunosuppressive action in experimental allergic encephalomyelitis and multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1972; 6(4):619-23. PubMed ID: 4564004
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCR usage in human and experimental demyelinating disease.
    Hafler DA; Saadeh MG; Kuchroo VK; Milford E; Steinman L
    Immunol Today; 1996 Apr; 17(4):152-9. PubMed ID: 8871344
    [No Abstract]   [Full Text] [Related]  

  • 34. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.
    Giuliani F; Metz LM; Wilson T; Fan Y; Bar-Or A; Yong VW
    J Neuroimmunol; 2005 Jan; 158(1-2):213-21. PubMed ID: 15589056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demyelinating diseases].
    Reznik M
    Rev Med Liege; 1972 Jan; 27(2):29-38. PubMed ID: 4552243
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.
    Raine CS; Traugott U
    Ann N Y Acad Sci; 1984; 436():33-51. PubMed ID: 6085228
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroglia and the myelin-bearing cell: a symposium. Immunological factors in experimental allergic encephalomyelitis and multiple sclerosis as revealed by cultures of mammalian nerve tissue.
    Bornstein MB
    J Neurol Neurosurg Psychiatry; 1969 Apr; 32(2):163-4. PubMed ID: 4306415
    [No Abstract]   [Full Text] [Related]  

  • 38. T-cell receptor genes. Germline polymorphisms and genetic susceptibility to demyelinating diseases.
    Hauser SL
    Ann N Y Acad Sci; 1995 Jul; 756():233-40. PubMed ID: 7645843
    [No Abstract]   [Full Text] [Related]  

  • 39. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease.
    Ercolini AM; Miller SD
    J Immunol; 2006 Mar; 176(6):3293-8. PubMed ID: 16517694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.